Zehnder, Yvonne; Risi, Simone; Michel, Dieter; Knecht, Hans; Perrelet, Romain; Kraenzlin, Marius; Zäch, Guido A; Lippuner, Kurt (2004). Prevention of bone loss in paraplegics over 2 years with alendronate. Journal of bone and mineral research, 19(7), pp. 1067-74. Hoboken, N.J.: Wiley-Blackwell 10.1359/JBMR.040313
Full text not available from this repository. (Request a copy)To assess the effects of long-term treatment of bone loss with alendronate in a group of paraplegic men, 55 patients were evaluated in a prospective randomized controlled open label study that was 2 years in duration comparing alendronate and calcium with calcium alone. Bone loss was stopped at all cortical and trabecular infralesional sites (distal tibial epiphysis, tibial diaphysis, total hip) with alendronate 10 mg daily.
Item Type: |
Journal Article (Original Article) |
|---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Orthopaedic, Plastic and Hand Surgery (DOPH) > Clinic of Osteoporosis |
UniBE Contributor: |
Perrelet, Romain, Lippuner, Kurt |
Subjects: |
600 Technology > 610 Medicine & health |
ISSN: |
0884-0431 |
Publisher: |
Wiley-Blackwell |
Language: |
English |
Submitter: |
Factscience Import |
Date Deposited: |
04 Oct 2013 15:24 |
Last Modified: |
05 Dec 2022 14:26 |
Publisher DOI: |
10.1359/JBMR.040313 |
PubMed ID: |
15176988 |
Web of Science ID: |
000222191600003 |
URI: |
https://boris.unibe.ch/id/eprint/37834 (FactScience: 211995) |
Actions (login required)
 |
Edit item |